Cannabinoids in the management of difficult to treat pain

References

• ABC News, USA Today, Stanford Medical Center PollBroad experience with pain sparks search for relief [online]2005 URL: http://abcnews.go.com/images/Politics/979a1TheFightAgainstPain.pdf
   Google Scholar
• AbramsDIHiltonJFLeiserRJShort-term effects of cannabinoids in patients with HIV-1 infection. A randomized, placbo-controlled clinical trialAnn Intern Med20031392586612965981
   PubMed Web of Science ®Google Scholar
• AbramsDIJayCAShadeSBCannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trialNeurology2007685152117296917
   PubMed Web of Science ®Google Scholar
• AgarwalNPacherPTegederICannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptorsNat Neurosci200710870917558404
   PubMed Web of Science ®Google Scholar
• AkermanSHollandPRGoadsbyPJCannabinoid (CB1) receptor activation inhibits trigeminovascular neuronsJ Pharmacol Exp Ther2007320647117018694
   PubMed Web of Science ®Google Scholar
• AkermanSKaubeHGoadsbyPJAnandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociceptionJ Pharmacol Exp Ther2003309 566314718591
   PubMed Web of Science ®Google Scholar
• AkermanSKaubeHGoadsbyPJAnandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptorsBr J Pharmacol200414213546015277315
   PubMed Web of Science ®Google Scholar
• AttalNBrasseurLGuirimandDAre oral cannabinoids safe and effective in refractory neuropathic pain?Eur J Pain20048173714987627
   PubMed Web of Science ®Google Scholar
• BanerjeeSPSnyderSHMechoulamRCannabinoids: influence on neurotransmitter uptake in rat brain synaptosomesJ Pharmacol Exp Ther19751947481168349
   PubMed Web of Science ®Google Scholar
• BarnesMPSativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic painExpert Opin Pharmacother200676071516553576
   PubMed Web of Science ®Google Scholar
• BarrettMLScuttAMEvansFJCannflavin A and B, prenylated flavones from Cannabis sativa LExperientia19864245233754224
   PubMedGoogle Scholar
• BasileACSertieJAFreitasPCAnti-inflammatory activity of oleoresin from Brazilian CopaiferaJ Ethnopharmacol19882210193352280
   PubMed Web of Science ®Google Scholar
• BeaulieuPEffects of nabilone, a synthetic cannabinoid, on postoperative pain: [Les effets de la nabilone, un cannabinoide synthetique, sur la douleur postoperatoire]Can J Anaesth2006537697516873343
   PubMed Web of Science ®Google Scholar
• BerlachDMShirYWareMAExperience with the synthetic cannabinoid nabilone in chronic noncancer painPain Med2006725916533193
   PubMed Web of Science ®Google Scholar
• BermanJSSymondsCBirchREfficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trialPain200411229930615561385
   PubMed Web of Science ®Google Scholar
• BisognoTHanusLDe PetrocellisLMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideBr J Pharmacol20011348455211606325
   PubMed Web of Science ®Google Scholar
• BlakeDRRobsonPHoMJubbRWPreliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritisRheumatology (Oxford)20064550216282192
   PubMed Web of Science ®Google Scholar
• British Medical AssociationTherapeutic uses of cannabis1997AmsterdamHarwood Academic Publishers142
   Google Scholar
• BroomSLSufkaKJElsohlyMAAnalgesic and reinforcing proerties of delta9-THC-hemisuccinate in adjuvant-arthritic ratsJournal of Cannabis Therapeutics2001117182
   Google Scholar
• BudneyAJHughesJRMooreBAReview of the validity and significance of cannabis withdrawal syndromeAm J Psychiatry200416119677715514394
   PubMed Web of Science ®Google Scholar
• BuggyDJToogoodLMaricSLack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative painPain20031061697214581124
   PubMed Web of Science ®Google Scholar
• BursteinSLevinEVaranelliCProstaglandins and cannabis. II. Inhibition of biosynthesis by the naturally occurring cannabinoidsBiochem Pharmacol1973222905104202579
   PubMed Web of Science ®Google Scholar
• CabralGRussoEBGrotenhermenFImmune systemCannabis and cannabinoids: Pharmacology, toxicology and therapeutic potential2001Binghamton, NYHaworth Press27987
   Google Scholar
• CalhounSRGallowayGPSmithDEAbuse potential of dronabinol (Marinol)J Psychoactive Drugs199830187969692381
   PubMed Web of Science ®Google Scholar
• CampbellFATramberMRCarrollDAre cannabinoids an effective and safe option in the management of pain? A qualitative systematic reviewBMJ20013231611440920
   PubMed Web of Science ®Google Scholar
• CarrierEJAuchampachJAHillardCJInhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppressionProc Natl Acad Sci USA2006103789590016672367
   PubMed Web of Science ®Google Scholar
• ChallapalliPVStinchcombALIn vitro experiment optimization for measuring tetrahydrocannabinol skin permeationInt J Pharm20022413293912100860
   PubMed Web of Science ®Google Scholar
• CichewiczDLMartinZLSmithFLEnhancement of mu opioid antinociception by oral delta9-tetrahydrocannabinol: Dose-response analysis and receptor identificationJ Pharmacol Exp Ther19992898596710215664
   PubMed Web of Science ®Google Scholar
• CichewiczDLMcCarthyEAAntinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administrationJ Pharmacol Exp Ther20033041010512604676
   PubMed Web of Science ®Google Scholar
• CichewiczDLWelchSPModulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinolJ Pharmacol Exp Ther2003305812712606610
   PubMed Web of Science ®Google Scholar
• ClarkPAltmanDAssessment of blinding in Phase III Sativex spasticity studies2006GW Pharmaceuticals56
   Google Scholar
• Clermont-GnamienSAtlaniSAttalNUtilisation thérapeutique du delta-9-tétrahydrocannabinol (dronabinol) dans les douleurs neuropathiques réfractaires. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]Presse Med20023139 Pt 11840512496714
   PubMed Web of Science ®Google Scholar
• DavisWMHatoumNSNeurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinolGen Pharmacol198314247526301931
   PubMedGoogle Scholar
• de MeijerEGuyGWWhittleBARobsonPThe breeding of cannabis cultivars for pharmaceutical end usesMedicinal uses of cannabis and cannabinoids2004LondonPharmaceutical Press5570
   Google Scholar
• DegenhardtLHallWLynskeyMTesting hypotheses about the relationship between cannabis use and psychosisDrug Alcohol Depend200371374812821204
   PubMed Web of Science ®Google Scholar
• DevaneWAHanusLBreuerAIsolation and structure of a brain constituent that binds to the cannabinoid receptorScience1992258194691470919
   PubMed Web of Science ®Google Scholar
• Di MarzoVMelckDBisognoTEndocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory actionTrends Neurosci19982152189881850
   PubMed Web of Science ®Google Scholar
• DogrulAGulHAkarATopical cannabinoid antinociception: synergy with spinal sitesPain200310511614499415
   PubMed Web of Science ®Google Scholar
• DysonAPeacockMChenAAntihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the ratPain20051161293715936883
   PubMed Web of Science ®Google Scholar
• ElSohlyMARossSAMehmedicZPotency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980–1997J Forensic Sci200045243010641915
   PubMed Web of Science ®Google Scholar
• ErnstGDenkeCReifMStandardized cannabis extract in the treatment of postherpetic neuralgia: a randomized, double-blind, placebo-controlled cross-over study2005International Association for Cannabis as Medicine2005 September 9Leiden, Netherlands
   Google Scholar
• EvansFJCannabinoids: The separation of central from peripheral effects on a structural basisPlanta Med199157S607
   PubMed Web of Science ®Google Scholar
• FimianiCLibertyTAquirreAJOpiate, cannabinoid, and eicosanoid signaling converges on common intracellular pathways nitric oxide couplingProstaglandins Other Lipid Mediat199957233410367294
   PubMed Web of Science ®Google Scholar
• FishmanSMPain and politics: DEA, Congress, and the courts, oh my!Pain Med2006787816533207
   PubMed Web of Science ®Google Scholar
• FitzgeraldGACoxibs and cardiovascular diseaseN Engl J Med200435117091115470192
   PubMed Web of Science ®Google Scholar
• Food and Drug AdministrationServices UDoHaHGuidance for industry: Botanical drug products2004US Government48
   Google Scholar
• FoxAKesinglandAGentryCThe role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic painPain2001929110011323130
   PubMed Web of Science ®Google Scholar
• FrideERussoEBOnaiviESugiuraTDi MarzoVNeuropsychiatry: Schizophrenia, depression, and anxietyEndocannabinoids: The brain and body’s marijuana and beyond2006Boca Raton, FLTaylor and Francis37182
   Google Scholar
• FrondiniCLanfranchiGMinardiMAffective, behavior and cognitive disorders in the elderly with chronic musculoskelatal pain: the impact on an aging populationArch Gerontol Geriatr200744Suppl 11677117317450
   PubMed Web of Science ®Google Scholar
• GaoniYMechoulamRIsolation, structure and partial synthesis of an active constituent of hashishJ Am Chem Soc19648616467
   Web of Science ®Google Scholar
• GausonLAStevensonLAThomasACannabigerol behaves as a partial agonist at both CB1 and CB2 receptors17th Annual Symposium on the Cannabinoids2007Saint-Sauveur, Quebec, CanadaInternational Cannabinoid Research Society206
   Google Scholar
• GerritsenMECarleyWWRangesGEFlavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expressionAm J Pathol1995147278927543732
   PubMed Web of Science ®Google Scholar
• GertschJRadunerSLeontiMScreening of plant extracts for new CB2-selective agonists revewals new players in Cannabis sativa17th Annual Symposium on the Cannabinoids2007Saint-Sauveur, Quebec, CanadaInternational Cannabinoid Research Society213
   Google Scholar
• GibsonSJIASP global year against pain in older persons: highlighting the current status and future perspectives in geriatric painExpert Rev Neurother200776273517563246
   PubMedGoogle Scholar
• GieringerDSt LaurentJGoodrichSCannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compoundsJournal of Cannabis Therapeutics20044727
   Google Scholar
• GilMLJimenezJOceteMAComparative study of different essential oils of Bupleurum gibraltaricum LamarckPharmazie19894428472772005
   PubMed Web of Science ®Google Scholar
• GomezMASaenzMTGarciaMDStudy of the topical anti-inflammatory activity of Achillea ageratum on chronic and acute inflammation modelsZ Naturforsch [C]19995493741
   PubMed Web of Science ®Google Scholar
• GorterRWButoracMCobianEPMedical use of cannabis in the NetherlandsNeurology200564917915753439
   PubMed Web of Science ®Google Scholar
• GrinspoonLBakalarJBMarihuana, the forbidden medicine1997New HavenYale University Pressxv296
   Google Scholar
• GrotenhermenFPharmacokinetics and pharmacodynamics of cannabinoidsClin Pharmacokinet2003423276012648025
   PubMed Web of Science ®Google Scholar
• GrotenhermenFCannabinoids for therapeutic use: designing systems to increase efficacy and reliabilityAmerican Journal of Drug Delivery2004222940
   Google Scholar
• GrotenhermenFLesonGBerghausGDeveloping science-based per se limits for driving under the influence of cannabis (DUIC)Findings and recommendations by an expert panel2005Hürth, GermanyNova- Institut49
   Google Scholar
• GuyGWRobsonPA Phase I, double blind, three-way crossover study to assess the pharmacokinetic profile of cannabis based medicine extract (CBME) administered sublingually in variant cannabinoid ratios in normal healthy male volunteers (GWPK02125)Journal of Cannabis Therapeutics2003312152
   Google Scholar
• HampsonAJGrimaldiMAxelrodJCannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidantsProc Natl Acad Sci USA1998958268739653176
   PubMed Web of Science ®Google Scholar
• HazekampARuhaakRZuurmanLEvaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinolJ Pharm Sci20069513081716637053
   PubMed Web of Science ®Google Scholar
• HerkenhamMLynnABLittleMDCannabinoid receptor localization in brainProc Natl Acad Sci USA199087193262308954
   PubMed Web of Science ®Google Scholar
• HohmannAGBrileyEMHerkenhamMPre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cordBrain Res1999822172510082879
   PubMed Web of Science ®Google Scholar
• HohmannAGMartinWJTsouKInhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2Life Sci199556211187776839
   PubMed Web of Science ®Google Scholar
• HohmannAGSuplitaRLBoltonNMAn endocannabinoid mechanism for stress-induced analgesiaNature200543511081215973410
   PubMed Web of Science ®Google Scholar
• HoldcroftAMazeMDoreCA multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain managementAnesthesiology20061041040616645457
   PubMed Web of Science ®Google Scholar
• HowlettACJohnsonMRMelvinLSNonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor modelMol Pharmacol1988332973023352594
   PubMed Web of Science ®Google Scholar
• HuestisMAHenningfieldJEConeEJBlood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuanaJ Anal Toxicol199216276821338215
   PubMed Web of Science ®Google Scholar
• JanseAFCBreekveldt-PostmaNSErkensJAMedicinal gebruik van cannabis.: PHARMO Instituut [Institute for Drug Outcomes Research]200451
   Google Scholar
• JohnsonJRPottsRCannabis-based medicines in the treatment of cancer pain: a randomised, double-blind, parallel group, placebo controlled, comparative study of the efficacy, safety and tolerability of Sativex and Tetranabinex in patients with cancer-related pain20053Edinburgh, Scotland 8–11
   Google Scholar
• JonesRTBenowitzNBachmanJClinical studies of cannabis tolerance and dependenceAnn N Y Acad Sci197628222139798533
   PubMed Web of Science ®Google Scholar
• JoyJEWatsonSJBensonJAJrMarijuana and medicine: Assessing the science base1999Washington, DCInstitute of Medicine
   Google Scholar
• KarsakMGaffalEDateRAttenuation of allergic contact dermatitis through the endocannabinoid systemScience20073161494717556587
   PubMed Web of Science ®Google Scholar
• KarstMSalimKBursteinSAnalgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trialJAMA200329017576214519710
   PubMed Web of Science ®Google Scholar
• KatonaSKaminskiESandersHCannabinoid influence on cytokine profile in multiple sclerosisClin Exp Immunol2005140580515932522
   PubMed Web of Science ®Google Scholar
• KingLACarpentierCGriffithsPCannabis potency in EuropeAddiction2005100884615954994
   PubMed Web of Science ®Google Scholar
• KoMCWoodsJHLocal administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid actionPsychopharmacology (Berl)1999143322610353438
   PubMed Web of Science ®Google Scholar
• KoganNMCannabinoids and cancerMini Rev Med Chem200559415216250836
   PubMed Web of Science ®Google Scholar
• LembergerLRubinAWolenRPharmacokinetics, metabolism and drug-abuse potential of nabiloneCancer Treat Rev19829Suppl B17236299550
   PubMed Web of Science ®Google Scholar
• LiJDaughtersRSBullisCThe cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in ratsPain199981253310353490
   PubMed Web of Science ®Google Scholar
• LigrestiAMorielloASStarowiczKAntitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinomaJ Pharmacol Exp Ther200631813758716728591
   PubMed Web of Science ®Google Scholar
• LiuJLiHBursteinSHZurierRBActivation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acidMol Pharmacol2003639839212695526
   PubMed Web of Science ®Google Scholar
• LorenzettiBBSouzaGESartiSJMyrcene mimics the peripheral analgesic activity of lemongrass teaJ Ethnopharmacol1991344381753786
   PubMed Web of Science ®Google Scholar
• LynchMEYoungJClarkAJA case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access RegulationsJ Pain Symptom Manage20063249750117085276
   PubMed Web of Science ®Google Scholar
• MackieKCannabinoid receptors as therapeutic targetsAnn Rev Pharmacol Toxicol2006461012216402900
   PubMed Web of Science ®Google Scholar
• MaidaVThe synthetic cannabinoid nabilone improves pain and symptom management in cancer patietnsBreast Cancer Res Treat20071031212
   Web of Science ®Google Scholar
• MalfaitAMGallilyRSumariwallaPFThe nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritisProc Natl Acad Sci USA2000979561610920191
   PubMed Web of Science ®Google Scholar
• ManzanaresJCorcheroJRomeroJChronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brainBrain Res Mol Brain Res199855126329645967
   PubMedGoogle Scholar
• MartinWJHohmannAGWalkerJMSuppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effectsJ Neurosci1996166601118815936
   PubMed Web of Science ®Google Scholar
• MassaFMonoryKEndocannabinoids and the gastrointestinal tractJ Endocrinol Invest2006293 Suppl475716751708
   PubMedGoogle Scholar
• McPartlandJMRussoEBCannabis and cannabis extracts: Greater than the sum of their parts?Journal of Cannabis Therapeutics2001110332
   Google Scholar
• MechoulamRBen-ShabatSHanusLIdentification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptorsBiochem Pharmacol19955083907605349
   PubMed Web of Science ®Google Scholar
• MehmedicZMartinJFosterSDelta-9-THC and other cannabinoids content of confiscated marijuana: potency trends, 1993-2003International Association of Cannabis as Medicine2005 September 10Leiden, Netherlands
   Google Scholar
• Müller-VahlKRSchneiderUKolbeHTreatment of Tourette’s syndrome with delta-9-tetrahydrocannabinolAm J Psychiatry1999156495
   PubMed Web of Science ®Google Scholar
• MunroSThomasKLAbu-ShaarMMolecular characterization of a peripheral receptor for cannabinoidsNature19933656157689702
   PubMed Web of Science ®Google Scholar
• NadulskiTPragstFWeinbergGRandomized double-blind placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extractTher Drug Monit2005a2779981016306858
   PubMed Web of Science ®Google Scholar
• NadulskiTSporkertFSchnelleMSimultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extractJ Anal Toxicol2005b29782916356335
   PubMed Web of Science ®Google Scholar
• NeffGWO’BrienCBReddyKRPreliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver diseaseAm J Gastroenterol2002972117912190187
   PubMed Web of Science ®Google Scholar
• NicholsonANTurnerCStoneBMEffect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adultsJ Clin Psychopharmacol2004243051315118485
   PubMed Web of Science ®Google Scholar
• NicolodiMVolpeARSicuteriFFibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: Their common cluesCephalalgia199818Suppl 214149533670
   PubMed Web of Science ®Google Scholar
• NotcuttWPriceMChapmanGClinical experience with nabilone for chronic painPharmaceutical Sciences199735515
   Google Scholar
• NotcuttWPriceMMillerRInitial experiences with medicinal extracts of cannabis for chronic pain: results from 34 “N of 1” studiesAnaesthesia2004594405215096238
   PubMed Web of Science ®Google Scholar
• NurmikkoTJSerpellMGHoggartBSativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trialPain2007In press
   Web of Science ®Google Scholar
• PacherPBatkaiSKunosGThe endocannabinoid system as an emerging target of pharmacotherapyPharmacol Rev20065838946216968947
   PubMed Web of Science ®Google Scholar
• PateDChemical ecology of cannabisJournal of the International Hemp Association19942327
   Google Scholar
• PérezJCombined cannabinoid therapy via na oromucosal sprayDrugs Today (Barc)20064249550116969427
   PubMed Web of Science ®Google Scholar
• PertweeRGCannabidiol as a potential medicine. In: Mechoulam R ed. Cannabinoids as therapeutics2005Basel, SwitzerlandBirkhäuser Verlag4765
   Google Scholar
• PopeHGJrGruberAJHudsonJINeuropsychological performance in long-term cannabis usersArch Gen Psychiatry2001589091511576028
   PubMed Web of Science ®Google Scholar
• RahnEJMakriyannisAHohmannAGActivation of cannabinoid CB(1) and CB(2) receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in ratsBr J Pharmacol2007113
   Web of Science ®Google Scholar
• RaoVSMenezesAMVianaGSEffect of myrcene on nociception in miceJ Pharm Pharmacol19904287781983154
   PubMed Web of Science ®Google Scholar
• ReLBarocciSSonninoSLinalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junctionPharmacol Res2000421778210887049
   PubMed Web of Science ®Google Scholar
• RichardsonJDAanonsenLHargreavesKMSR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated miceEur J Pharmacol1997319R349042616
   PubMed Web of Science ®Google Scholar
• RichardsonJDAanonsenLHargreavesKMAntihyperalgesic effects of spinal cannabinoidsEur J Pharmacol1998a345145539600630
   PubMed Web of Science ®Google Scholar
• RichardsonJDAanonsenLHargreavesKMHypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesiaJ Neurosci1998b1845179412521
   PubMed Web of Science ®Google Scholar
• RichardsonJDKiloSHargreavesKMCannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptorsPain1998c7511199539680
   PubMed Web of Science ®Google Scholar
• RogDJNurmikoTFriedeTRandomized controlled trial of cannabis based medicine in central neuropathic pain due to multiple sclerosisNeurology2005658121916186518
   PubMed Web of Science ®Google Scholar
• RussoECannabis for migraine treatment: The once and future prescription? An historical and scientific reviewPain199876389696453
   PubMed Web of Science ®Google Scholar
• RussoEBHemp for headache: An in-depth historical and scientific review of cannabis in migraine treatmentJournal of Cannabis Therapeutics200112192
   Google Scholar
• RussoEBClinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?Neuroendocrinol Lett20042531915159679
   PubMed Web of Science ®Google Scholar
• RussoEBColeBEBoswellMThe role of cannabis and cannabinoids in pain managementWeiner’s Pain Management: A Practical Guide for Clinicians2006a7Boca Raton, FLCRC Press82344
   Google Scholar
• RussoEBSchatmanMEThe solution to the medicinal cannabis problemEthical issues in chronic pain management2006bBoca Raton, FLTaylor and Francis165194
   Google Scholar
• RussoEBGuyGWA tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiolMed Hypotheses2006662344616209908
   PubMed Web of Science ®Google Scholar
• RussoEBGuyGWRobsonPJCannabis, pain and sleep: lessons from therapeutic clinical trials of Sativex® cannabis based medicineChem Biodivers2007a417294317712817
   PubMed Web of Science ®Google Scholar
• RussoEBMathreMLByrneAChronic cannabis use in the Compassionate Investigational New Drug Program: An examination of benefits and adverse effects of legal clinical cannabisJournal of Cannabis Therapeutics20022357
   Google Scholar
• SamahaANRobinsonTEWhy does the rapid delivery of drugs to the brain promote addiction?Trends Pharmacol Sci20052682715681025
   PubMed Web of Science ®Google Scholar
• SarchielliPPiniLACoppolaFEndocannabinoids in chronic migraine: CSF findings suggest a system failureNeuropsychopharmacology20073213849017119542
   PubMed Web of Science ®Google Scholar
• SchaeferCFBrackettDJGunnCGDecreased platelet aggregation following marihuana smoking in manJ Okla State Med Assoc1979724356521861
   PubMedGoogle Scholar
• SchleyMLeglerASkoppGDelta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain reliefCurr Med Res Opin20062212697616834825
   PubMed Web of Science ®Google Scholar
• ShenMPiserTMSeyboldVSCannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal culturesJ Neurosci1996164322348699243
   PubMed Web of Science ®Google Scholar
• SmithNTA review of the published literature into cannabis withdrawal symptoms in human usersAddiction2002976213212084124
   PubMed Web of Science ®Google Scholar
• SolowijNStephensRSRoffmanRACognitive functioning of long-term heavy cannabis users seeking treatmentJAMA200228711233111879109
   PubMed Web of Science ®Google Scholar
• SpadoneCNeurophysiologie du cannabis [Neurophysiology of cannabis]Encephale19911717221688273
   PubMedGoogle Scholar
• StottCGAyerakwaLWrightSLack of human cytochrome P450 induction by Sativex17th Annual Symposium on the Cannabinoids2007Saint-Sauveur, Quebec, CanadaInternational Cannabinoid Research Society211
   Google Scholar
• StottCGGuyGWWrightSThe effects of cannabis extracts Tetranabinex and Nabidiolex on human cyclo-oxygenase (COX) activity2005aInternational Cannabinoid Research SocietyJune 2005Clearwater, FL
   Google Scholar
• StottCGGuyGWWrightSThe effects of cannabis extracts Tetranabinex and Nabidiolex on human cytochrome P450-mediated metabolism2005bInternational Cannabinoid Research AssociationJune 27 2005Clearwater, FL163
   Google Scholar
• StrangmanNMWalkerJMCannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responsesJ Neurophysiol199982472710400973
   PubMed Web of Science ®Google Scholar
• SvendsenKBJensenTSBachFWDoes the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trialBMJ200432925315258006
   PubMed Web of Science ®Google Scholar
• TambeYTsujiuchiHHondaGGastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllenePlanta Med199662469709005452
   PubMed Web of Science ®Google Scholar
• TashkinDPSmoked marijuana as a cause of lung injuryMonaldi Arch Chest Dis2005639310016128224
   PubMedGoogle Scholar
• TopolEJFailing the public health ’ rofecoxib, Merck, and the FDAN Engl J Med20043511707915470193
   PubMed Web of Science ®Google Scholar
• VolfeZDvilanskyANathanICannabinoids block release of serotonin from platelets induced by plasma from migraine patientsInt J Clin Pharmacol Res1985524362997048
   PubMedGoogle Scholar
• WadeDTMakelaPRobsonPDo cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patientsMult Scler2004104344115327042
   PubMed Web of Science ®Google Scholar
• WadeDTMakelaPMHouseHLong-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosisMult Scler2006126394517086911
   PubMed Web of Science ®Google Scholar
• WadeDTRobsonPHouseHA preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptomsClin Rehabil2003171826
   Web of Science ®Google Scholar
• WalkerJMHohmannAGMartinWJThe neurobiology of cannabinoid analgesiaLife Sci1999a656657310462067
   PubMed Web of Science ®Google Scholar
• WalkerJMHuangSMStrangmanNMPain modulation by the release of the endogenous cannabinoid anandamideProc Nat Acad Sci USA1999b961219820310518599
   PubMed Web of Science ®Google Scholar
• WalkerJMHuangSMCannabinoid analgesiaPharmacol Ther2002951273512182960
   PubMed Web of Science ®Google Scholar
• WareMWangWShapiroSSmoked cannabis for chronic neuropathic pain: results of a pilot study17th Annual Symposium on the Cannabinoids2007Saint-Sauveur, Quebec, CanadaInternational Cannabinoid Research Societyp31
   Google Scholar
• WirthPWWatsonESElSohlyMAnti-inflammatory properties of cannabichromeneLife Sci198026199157401911
   PubMed Web of Science ®Google Scholar
• WrightSGWMS001 and GWMS0106: maintenance of blinding2005LondonGW Pharmaceuticals8
   Google Scholar
• ZajicekJFoxPSandersHCannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialLancet200336215172614615106
   PubMed Web of Science ®Google Scholar
• ZajicekJPSandersHPWrightDECannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow upJ Neurol Neurosurg Psychiatry2005761664916291891
   PubMed Web of Science ®Google Scholar
• ZuardiAWGuimaraesFSMathreMLCannabidiol as an anxiolytic and antipsychoticCannabis in medical practice: a legal, historical and pharmacological overview of the therapeutic use of marijuana1997Jefferson, NCMcFarland13341
   Google Scholar